Stable Isotope Labeled Compounds Market Worth $312 Million by 2024
According to the new market research report "Stable Isotope Labeled Compounds Market
by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical
Diagnostics, Industrial), End User (Pharmaceutical &
Biopharmaceutical Companies, Academic institute), Region – Global
Forecast to 2024", published by MarketsandMarkets™, the Stable Isotope
Labeled Compounds Market is projected to grow at a CAGR of 3.0% during
the forecast period to reach USD 312 million by 2024 from USD 269
million in 2019.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199
The
Factors such as the increase in research activities in the
pharmaceutical and biotechnology sector, rising proteomics research, and
the rising prevalence of cancer.
The H-2 labeled compounds segment accounted for the largest share of the Stable Isotope Labeled Compounds Market.
Based
on type, the stable isotope labeled compounds industry is segmented
into C-13, N-15, O-18, H-2 (deuterium), and other isotopes. The H-2
labeled compounds segment accounted for the largest share of the stable
isotope-labeled compounds market in 2019. The large share of this
segment can be attributed to the increasing pharmaceutical research
conducted using deuterium and the growing nuclear industry. This growth
in this segment is driven primarily by increasing drug research in the
pharmaceutical industry and the rising availability of deuterium-labeled
compounds.
Browse in-depth TOC on "Stable Isotope Labeled Compounds Market"
118 – Tables
21 – Figures
135 – Pages
The research segment accounted for the largest share of the Stable Isotope Labeled Compounds Market in 2019.
Based
on application, the Stable Isotope Labeled Compound Market is segmented
into research, clinical diagnostics, industrial applications, and other
applications. The research segment accounted for the largest share of
the stable isotope-labeled compounds market in 2019, owing to rising
research activities in the biomedical, pharmaceutical, environmental
& ecological, and agricultural sectors.
North America to dominate the stable isotope labeled compounds systems industry during the forecast period
In
2019, North America dominated the Stable Isotope Labeled Compounds
Market, followed by Europe. The major factors driving the growth of this
market include the growth of the pharmaceutical and biopharmaceutical
industry, the large nuclear industry in the US, the growth of the
Canadian pharmaceutical industry, and the availability of funding in
North American countries.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=53034199
The
prominent players in this market include PerkinElmer Inc. (US), Merck
KGaA (Germany), Cambridge Isotope Laboratories, Inc. (US), URENCO
Limited (UK), IsoSciences, LLC (US), Medical Isotopes, Inc. (US),
Omicron Biochemicals, Inc. (US), Trace Sciences International (US),
Alsachim (France), Taiyo Nippon Sanso Corporation (Japan), and Rotem
Industries Israel Ltd. (Israel).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Comments
Post a Comment